LIPOCINE INC. Capital Expenditures
LIPOCINE INC. (LPCN) reported Capital Expenditures of $90.09 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-10
- LIPOCINE INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $10.02K, a 9.29% increase year-over-year.
- LIPOCINE INC. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $9.17K, a 90.52% decline year-over-year.
- LIPOCINE INC. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $0.00.
- LIPOCINE INC. payments to acquire property, plant, and equipment for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. payments to acquire property, plant, and equipment for fiscal 2024 was $90.09K, a 584.18% increase from fiscal 2023.
- LIPOCINE INC. payments to acquire property, plant, and equipment for fiscal 2023 was $13.17K, a 90.16% decline from fiscal 2022.
- LIPOCINE INC. payments to acquire property, plant, and equipment for fiscal 2022 was $133.83K, a 1663.02% increase from fiscal 2021.
- LIPOCINE INC. payments to acquire property, plant, and equipment for fiscal 2021 was $7.59K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $10.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $90.09K 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $80.07K 10-Q · filed 2025-11-06 | ||||
| 2023-12-31 | $9.17K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $9.17K derived: sum of 2 quarters · filed 2025-03-13 | $9.17K derived: sum of 3 quarters · filed 2025-03-13 | $13.17K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $4.00K 10-Q · filed 2024-11-07 | $100.73K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.00K 10-Q · filed 2024-08-08 | $100.73K derived: sum of 3 quarters · filed 2024-08-08 | $100.73K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-09 | $100.73K derived: sum of 2 quarters · filed 2024-05-09 | $100.73K derived: sum of 3 quarters · filed 2024-05-09 | $111.03K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $96.73K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $96.73K derived: sum of 2 quarters · filed 2024-03-07 | $107.03K derived: sum of 3 quarters · filed 2024-03-07 | $133.83K 10-K · filed 2024-03-07 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $10.30K derived: sum of 2 quarters · filed 2023-11-08 | $37.10K 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $10.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $37.10K 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | $26.80K 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | $7.59K 10-K · filed 2023-03-10 | ||||
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | $0.00 derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $0.00 10-Q · filed 2017-08-07 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $0.00 derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $20.45K derived: sum of 4 quarters · filed 2019-03-06 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $20.45K derived: sum of 3 quarters · filed 2019-03-06 | $59.65K 10-K · filed 2019-03-06 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $20.45K derived: sum of 2 quarters · filed 2017-11-08 | $59.65K 10-Q · filed 2017-11-08 | $59.65K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | $20.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $59.65K 10-Q · filed 2017-08-07 | $59.65K derived: sum of 3 quarters · filed 2018-03-12 | $73.56K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-03-31 | $39.20K 10-Q · filed 2017-05-08 | $39.20K derived: sum of 2 quarters · filed 2018-03-12 | $53.11K derived: sum of 3 quarters · filed 2018-03-12 | $54.66K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2015-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $13.91K derived: sum of 2 quarters · filed 2018-03-12 | $15.46K derived: sum of 3 quarters · filed 2018-03-12 | $28.69K 10-K · filed 2018-03-12 | |
| 2015-09-30 | $13.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $15.46K derived: sum of 2 quarters · filed 2016-11-08 | $28.69K 10-Q · filed 2016-11-08 | $67.02K derived: sum of 4 quarters · filed 2017-03-06 | |
| 2015-06-30 | $1.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $14.78K 10-Q · filed 2016-08-09 | $14.80K 10-Q · filed 2015-08-11 | $53.11K derived: sum of 3 quarters · filed 2017-03-06 | $72.52K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $13.23K 10-Q · filed 2016-05-09 | $51.56K derived: sum of 2 quarters · filed 2017-03-06 | $70.97K derived: sum of 3 quarters · filed 2017-03-06 | $70.97K derived: sum of 4 quarters · filed 2017-03-06 | |
| 2014-12-31 | $38.33K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $57.74K derived: sum of 2 quarters · filed 2017-03-06 | $57.74K derived: sum of 3 quarters · filed 2017-03-06 | $59.61K 10-K · filed 2017-03-06 | |
| 2014-09-30 | $19.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $19.41K derived: sum of 2 quarters · filed 2015-11-12 | $21.28K 10-Q · filed 2015-11-12 | $21.28K derived: sum of 4 quarters · filed 2015-11-12 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $1.87K 10-Q · filed 2015-08-11 | $1.87K derived: sum of 3 quarters · filed 2015-08-11 | $1.87K derived: sum of 4 quarters · filed 2015-08-11 | |
| 2014-03-31 | $1.87K 10-Q · filed 2015-05-07 | $1.87K derived: sum of 2 quarters · filed 2015-05-07 | $1.87K derived: sum of 3 quarters · filed 2015-05-07 | $1.87K derived: sum of 4 quarters · filed 2015-05-07 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $0.00 derived: sum of 2 quarters · filed 2015-03-11 | $0.00 derived: sum of 3 quarters · filed 2015-03-11 | $1.21K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $1.21K 10-Q · filed 2014-11-10 | $1.14K derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $1.21K 10-Q · filed 2014-08-13 | $1.14K derived: sum of 3 quarters · filed 2014-08-13 | ||
| 2013-03-31 | $1.21K 10-Q · filed 2014-05-13 | $1.14K derived: sum of 2 quarters · filed 2014-05-13 | |||
| 2012-12-31 | -$70.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $12.32K 10-K · filed 2014-03-31 | |||
| 2012-09-30 | $12.39K 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |